Advertisement
Hydroxychloroquine does not improve outcomes in COVID-19

Hydroxychloroquine Does Not Improve COVID-19 Pneumonia Outcomes

0
Second study shows no benefit versus standard of care in probability of negative conversion by 28 days
Sociodemographic factors associated with the risk for a positive severe acute respiratory syndrome coronavirus 2 test result include deprivation

Factors ID’d for Positive SARS-CoV-2 Test Result in Primary Care

0
Sociodemographic risk factors include male sex, deprivation, population density, ethnicity, obesity
Millennial and Generation X medical residents and fellows experience similar rates of burnout and have similar levels of empathy

Burnout Comparable Between Millennial, Gen X Residents, Fellows

0
Length of medical-system exposure, not generational traits, contribute to burnout
Obesity is associated with a significantly increased risk for progression to severe COVID-19

Obesity Tied to Increased Risk for Progression to Severe COVID-19

0
Authors urge close monitoring, prompt treatment for obese patients with COVID-19
The scores for mental health symptoms in medical personnel responding to COVID-19 pneumonia are generally higher than the norm in China

Mental Health Symptoms Up for Medics Dealing With COVID-19

0
Mean Symptom Checklist-90 score significantly higher for medical personnel responding to COVID-19
Older adults with both dementia and self-reported visual impairment may be at higher risk for disability than adults with only one of these conditions

Co-Occurring Visual Impairment, Dementia Heighten Disability Risk

0
Links seen to mobility, self-care, household activity among older adults with either, both conditions
Administration of convalescent plasma seems safe and results in improvement in clinical status for patients with severe or life-threatening COVID-19

Convalescent Plasma Appears Promising for Severe COVID-19

0
In series of 25 patients, 19 experienced improvement in clinical status by day 14; 11 were discharged
In a joint guidance document issued by the American Society for Bone and Mineral Research

Guidance Issued for Osteoporosis Management During COVID-19

0
Alternative methods for parenteral treatments include off-site clinics, home visit, self-injection
An experimental vaccine against COVID-19 appears to be safe and to trigger an immune response

Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response

0
Findings from early-stage trial that started in March and included eight healthy people receiving two doses
For patients with atrial fibrillation

Osteoporotic Fracture Risk Lower for DOAC Than Warfarin in A-Fib

0
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants